New evidence supporting the benefit of selective BET inhibition in the treatment of cardiovascular disease, chronic kidney disease and neurodegenerative […]
CALGARY, Alberta, Nov. 28, 2018 (GLOBE NEWSWIRE) — Shaw Communications Inc. (“Shaw”) announced today the filing with Canadian securities regulators […]